Sub-saharan Francophone Africa Symposium

• Welcome Note
  Mr. Pierre Dimba – Minister of Health, Côte d’Ivoire
• Welcome and Introduction
  Prof. Alex Vortsters
  HE Dr. Zainab Shinkafi Bagudu
  Dr Kiyali Ouattara
• Participants Introduction

Chairs: Blaise Guezo-Mevo (EPI, Benin) & Crispin Kazadi (EPI, Democratic Republic of Congo)

• Cervical cancer disease burden in the region/ HPV related cancers incidence and mortality in Africa
  Joseph Biey (WHO)
• HPV vaccination programs – regional overview
  Anissa Sidibe (WHO)
• Q&A

Chairs: Prof Yawo Atakouma (NITAG, Togo) & Serge Aimé Sawadogo (NITAG, Burkina Faso)

• Keynote presentation from Gavi: Funding mechanism, Multi-age cohort catch-up financing, technical assistance – introducing and revitalizing HPV vaccination programs
  Emily Kobayashi (Gavi)
• Gavi application process and lessons learned: country experience from Burundi
  Bellejoie Louise (EPI, Burundi)
• Key components of application: decision-making process, selecting and estimating target population, and budgeting
  Country experiences:
  • Ibrahim Diarra (EPI, Mali)
  • Landry Kaucley (EPI, Bénin)
• Q&A

Chairs: Joseph Biey (WHO) & Pierre Ongolo Zogo (NITAG, Cameroun)

• Overview of single-dose evidence
  Cathy Ndiaye (PATH)
• Decision-making, planning and Implementation (including coverage) of single-dose: experience from Cameroon
  Andreas Ateke Njoh (EPI, Cameroun)
• Single-dose decision-making and implementation experience 
  Country Examples:
  Hèzouwè Hervé Looky-Djobo (EPI, Togo)
  Evanilda Santos (EPI, Cap-Vert) – online
• Q&A and panel discussion:
  Panelists: Emily Kobayashi (Gavi), country representatives

Chairs: Andreas Ateke Njoh (EPI, Cameroon) & Anissa Sidibe (WHO)

• Cost and operational context for national HPV vaccine delivery
  Cathy Ndiaye (PATH)
• HPV vaccine delivery strategy, including conflict-affected areas – experience from Burkina Faso
  René Didace Bakouan (EPI, Burkina Faso)
• Current delivery strategies: overview and way forward to optimizing sustainable delivery strategies
  • Youssou Mbaye (EPI, Sénégal)
  • Innocent Massenon (EPI, Côte d’Ivoire)
• Q&A
• Panel: What are optimal and sustainable delivery strategies for HPV vaccine delivery? Discuss routine vaccination concepts in the countries, campaign approaches and nuances around it
  Panelist from EPI Senegal, Côte d’Ivoire, Burkina Faso, Mauritanie and Cameroon
  

• Africa HPV Roadshow: Accelerating HPV vaccination demand post-Covid-19.
  • Dr. Tene-Alima ESSOH
• HPV vaccine delivery strategy in Cameroon: Progress with the gender-neutral single-dose protocol three years after its introduction
  • Dr. Andreas Ateke Njoh
• Prevalence of Human Papillomavirus (HPV) infection among women in Togo in 2019.
  • Dr. Yawo Tufa Nyasenu
• The single-dose HPV vaccine: an opportunity to accelerate the elimination of cervical cancer in Sub-Saharan Africa
  • Dr. Freddy Gnangnon
• Reaching out of school girls with HPV vaccine using community outreach in Jigawa, Nigeria.
  • Saleh A. Kwaru Jabeer
• Human papillomavirus (HPV) vaccine implementation in Abia State, Nigeria: Lessons learnt from vaccinations in schools.
  • Chidinma Amuzie
• Distribution of high-risk human papillomavirus (HR-HPV) by human immunodeficiency virus (HIV) status in women with cervical cancer in Abidjan, Côte d’Ivoire, 2018-2020.
  • Dr Simon Boni.
• Achieving success in new vaccines introduction through effective planning and establishment of readiness: A case study of Nigeria’s HPV vaccine introduction.
  • Aisha Umar
• Integrating HPV vaccination of young girls with screening for pre-cancerous cervical lesions (PCL-CU): Effectiveness of awareness raising, social mobilization and advocacy in Burkina Faso.
  • Dr Claude Linda Traoré
• Advocacy and community mobilization program for vaccination against human papillomavirus (HPV) in Niger.
  • Dr Moubarak Ibrahima Madougou
• Research to assess the impact and acceptability of a Controlled Temperature Chain (CTC) on HPV vaccination.
  • Dr Yao Kossia
• Operationalizing the integration of HPV vaccination in school and university health services: Adolescent and youth health: The case of Côte d’Ivoire.
  • Kouassi Séraphin
• The role of civil society organizations in HPV prevention: KENYERA – Burundi.
  • Dr. Jean Claude MUDENDE
• Vaccination campaign for the multi-age cohort (MAC) of girls aged 9 to 18 in Côte d’Ivoire in 2024.
  • Dr. Viou Innocent MASSENON
• Experience of the Democratic Republic of Congo in the decision-making process for the introduction of the HPV vaccine.
  • Dr Djeneba Coulibaly-Traoré

Chairs: Mansour Niang (LISCA, Sénégal) & Kouakou Séraphin Kouassi (Jhpiego, Côte d’Ivoire)

• Role of Civil Society Organizations s in HPV Vaccination programs.
  Melanie Samson (UICC) – online
• Countries’ experience on stakeholder engagement: challenges and opportunities
  Mohamedou Ould Mohamed Salem (EPI, Mauritanie)
  Kone Fatoumata (EPI, Côte d’Ivoire)
• Panel Discussion on stakeholders engagement – How can we optimize the multi-sectoral coordination? Which stakeholders need to be engaged?
  • Civil Society Organizations: Nayi Zongo (Burkina Faso)
  • Ministry of Education: Abdourahamane A Maiga (Mali)
  • Yonta nana Yannick aimée epse (Cameroon)
  • Ayereoue/Balima Delphine (Burkina Faso)
  • Guei Fidèle (Côte d’Ivoire)
  • M. Ouattara Samala (Côte d’Ivoire)
  • Ibrahim Leye (NITAG, Sénégal)
  • Elizabeth Hassan (EPI, Nigéria)

• Welcome Note & Overview of Agenda for day 2
  Alex Vorsters & Emilie Karafillakis (University of Antwerp)

Chairs: Paul Bloem (WHO) & René Didace BAKOUAN (EPI, Burkina Faso)

• Monitoring global coverage for HPV vaccination programs.
  Paul Bloem (WHO)
• Country level monitoring and evaluation, including reporting tools, supervision and impact evaluation: country experiences
  Moussa Salatou Diagana (EPI, Mauritanie)
  Kone Fatoumata (EPI, Côte d’Ivoire)
• Q&A

Chairs: H.E. Dr. Zainab Shinkafi Bagudu (Medicaid Cancer Foundation) & Emilie Karafillakis (LSHTM)

• Key-note presentation – Social Mobilization (including  religious leaders), Communication and Training of HCPs: Nigeria’s Introduction Experience
  Elizabeth Hassan (NPHCDA, Nigéria)
• Q&A
• Communication plan based on community engagement – experience from Cameroon
  Jean Napani Claude (EPI, Cameroon)
• Communication and social mobilization at the district level: how to move forward?
  Aboubacar Diop (Superviseur Programme Elargi de Vaccination et de la Surveillance Epidémiologique, Sénégal)
• Crisis Communication & Training of HCPs in Cote d’Ivoire: key lessons learned from a high vs low coverage regions
  Yeboua Amoikon (EPI, Côte d’Ivoire)
• Q&A – Open Plenary on Training of HCPs and Communication Strategies: how can we optimize communication strategies and training of HCPs based on the HPV introduction experience
  Country representation: Mali, Burkina Faso, Senegal, Mauritanie and Cameroon

Chairs: Kone Fatoumata (EPI, Côte d’Ivoire) & Joseph Biey (WHO)

• Pink ribbon integration experience from Senegalrose au Sénégal
  Madjiguéne Ndiaye (EPI, Sénégal)
• Integration of HPV vaccination programs with adolescent health services:
  Expérience du Burkina Faso : René Didace Bakouan (EPI, Burkina Faso)
  Expérience du Togo: (EPI, Togo)
• Q&A

Chairs: CHIC Secretariat

• Countries working group according to status of HPV vaccination program
  To identify the key challenges, strengths and opportunities (3-5 of each) to HPV vaccination uptake (decision-making, introduction, sustainable coverage recovery)
• Plenary feedback (5 minutes per group)

• Summary & Concluding Remarks